- Home
- NXPL vs NRSN Comparison
NXPL vs NRSN Comparison
Compare NXPL & NRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPL
- NRSN
- Stock Information
- Founded
- NXPL 1997
- NRSN 2017
- Country
- NXPL United States
- NRSN Israel
- Employees
- NXPL N/A
- NRSN N/A
- Industry
- NXPL Telecommunications Equipment
- NRSN Biotechnology: Pharmaceutical Preparations
- Sector
- NXPL Telecommunications
- NRSN Health Care
- Exchange
- NXPL Nasdaq
- NRSN Nasdaq
- Market Cap
- NXPL 19.5M
- NRSN 17.8M
- IPO Year
- NXPL N/A
- NRSN 2021
- Fundamental
- Price
- NXPL $1.11
- NRSN $1.09
- Analyst Decision
- NXPL
- NRSN Hold
- Analyst Count
- NXPL 0
- NRSN 1
- Target Price
- NXPL N/A
- NRSN N/A
- AVG Volume (30 Days)
- NXPL 889.1K
- NRSN 374.5K
- Earning Date
- NXPL 11-14-2024
- NRSN 12-18-2024
- Dividend Yield
- NXPL N/A
- NRSN N/A
- EPS Growth
- NXPL N/A
- NRSN N/A
- EPS
- NXPL N/A
- NRSN N/A
- Revenue
- NXPL $66,482,000.00
- NRSN N/A
- Revenue This Year
- NXPL N/A
- NRSN N/A
- Revenue Next Year
- NXPL N/A
- NRSN N/A
- P/E Ratio
- NXPL N/A
- NRSN N/A
- Revenue Growth
- NXPL 179.89
- NRSN N/A
- 52 Week Low
- NXPL $0.71
- NRSN $0.51
- 52 Week High
- NXPL $2.68
- NRSN $2.33
- Technical
- Relative Strength Index (RSI)
- NXPL 48.71
- NRSN 47.35
- Support Level
- NXPL $1.09
- NRSN $1.01
- Resistance Level
- NXPL $2.30
- NRSN $1.13
- Average True Range (ATR)
- NXPL 0.21
- NRSN 0.09
- MACD
- NXPL -0.03
- NRSN -0.01
- Stochastic Oscillator
- NXPL 5.56
- NRSN 27.27
About NXPL NextPlat Corp
NextPlat Corp is a global e-commerce and healthcare company. Its e-commerce venues form an effective global network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operate in two segments: e-Commerce Business and Healthcare Business.
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.